Polyphosphazenes, methods of making, and uses thereof

Patent metadata

Field	Value
Publication number	US-11472927-B2
Application number	US-201615777135-A
Country	US
Kind code	B2
Filing date	Nov 18, 2016
Priority date	Nov 18, 2015
Publication date	Oct 18, 2022
Grant date	Oct 18, 2022

Abstract

Provided are polyphosphazenes and methods of making and using the polyphosphazenes. The polyphosphazenes can be essentially chloride free. The polyphosphazenes can be phosphazene polyacids. The polyphosphazenes can be used as surface coatings, or as adjuvants when combined with antigens.

First claim

The invention claimed is:

1. A polyphosphazene product having the following structure:

a salt thereof, or a crosslinked analog thereof, wherein R′ and R″ are a combination of carboxylatophenoxy groups and trifluoroethoxy groups;
wherein n is an integer from 10 to 500,000, and
the polyphosphazene product has less than 2% by weight chloride, wherein the polyphosphazene product when placed in an aqueous solution results in no detectable aggregates.

2. The polyphosphazene product of claim 1 , wherein the polyphosphazene product is a salt and the cation is selected from ammonium, potassium, sodium, calcium, iron, magnesium, quaternary ammonium, spermine, spermidine, and combinations thereof.

3. The polyphosphazene product of claim 1 , wherein the polyphosphazene product is crosslinked covalently or noncovalently.

4. A composition comprising one or more polyphosphazene product of claim 1 .

5. The composition of claim 4 , wherein the composition further comprises a pharmaceutically acceptable carrier.

6. The composition of claim 4 , wherein the composition further comprises one or more salts, wherein the one or more salts do not comprise a chloride ion.

7. The composition of claim 4 , wherein at least one of the one or more polyphosphazenes product are crosslinked covalently or non-covalently.

8. The composition of claim 4 , wherein the composition further comprises an immunologically active compound and the immunologically active compound is encapsulated by the crosslinked polyphosphazene product.

9. A method of making the polyphosphazene product of claim 1 comprising:
a) providing a reaction mixture comprising a polyphosphazene having the following structure:

a salt thereof, or a crosslinked analog thereof, wherein R′ and R″ are a combination of carboxylatophenoxy groups and trifluoroethoxy groups,
b) adjusting the pH of the reaction mixture with a chloride-free acid such that a precipitate comprising the polyphosphazene product is formed; and
c) separating the precipitate from the reaction mixture to provide a polyphosphazene product of claim 1 .

10. The method of claim 9 , wherein the pH of the reaction mixture does not go below 3.0, but does not exceed 6.5.

11. The method of claim 9 , wherein the pH of the reaction mixture is adjusted by adding an acid salt comprising monovalent cations to the reaction mixture.

12. The method of claim 11 , wherein the acid salt is selected from the group potassium hydrogen phthalate, disodium hydrogen phthalate, dipotassium hydrogen phthalate, sodium citrate, sodium acetate, sodium dihydrogen orthophospate, potassium dihydrogen orthophosphate, or disodium hydrogen orthophosphate.

13. The method of claim 9 , wherein the pH of the reaction mixture is adjusted by addition of carbon dioxide to the reaction mixture.

Assignees

• Univ Maryland

Inventors

• Andrianov Alexander K
• Marin Alexander
• Fuerst Thomas R

Classifications

• A61K2039/55511

  Organic adjuvants · CPC title

• A61K39/39 Primary

  characterised by the immunostimulating additives, e.g. chemical adjuvants · CPC title

• C08G79/025 Primary

  Polyphosphazenes · CPC title